Trestolone was first described in 1963. Subsequently, it was not studied again until 1990. Development of trestolone for potential clinical use started by 1993 and continued there after. No additional development appears to have been conducted since 2013. The medication was developed by the Population Council, anon-profit, non-governmental organization dedicated to reproductive health.